In a January 2026 analysis, the most-engaged Noom GLP-1Rx Program membersthose who use the Noom app most frequentlylost 25.2% more weight, on average, by week 40, than the least-engaged members (comparing the top and bottom quartiles based on engagement)
Namenda (memantine HCl) acts as an N-methyl-D-aspartate (NMDA) receptor antagonist designed to limit glutamate excitotoxicity and resulting neuronal damage [19,22,23]
Different GLP-1 medications reach steady-state concentrations at different ratesliraglutide within approximately 3 days, dulaglutide within 24 weeks, and semaglutide within 45 weeks
49.5% women), 18,725 patients newly prescribed GLP-1 receptor agonists (mean age, 47.1 years
13 Investigations in humans have used 15 mg/kg as an oral bolus to increase the plasma GSH concentration two- to fivefold
Frias, E